Terns Pharmaceuticals, Inc.TERNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-89M

+1.5% YoY

Free Cash Flow

$-70M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	1	0	0	0
Gross Profit	0	1	0	0	0
Operating Income	-37	-50↓34.7%	-62↓24.4%	-103↓65.3%	-102↑0.7%
Net Income	-29	-50↓70.9%	-60↓20.3%	-90↓49.5%	-89↑1.5%
EBITDA	-37	-49↓34.7%	-61↓23.6%	-102↓66.7%	-101↑0.7%
EPS Diluted	-1.61	-1.98↓23.0%	-1.67↑15.7%	-1.27↑24.0%	-1.12↑11.8%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	75	48↓36.3%	143↑200.3%	80↓44.2%	161↑102.0%
Total Current Assets	91	167↑83.7%	285↑70.8%	267↓6.2%	362↑35.4%
Total Assets	92	168↑82.1%	287↑70.8%	269↓6.4%	364↑35.5%
Total Current Liabilities	23	7↓70.1%	8↑24.2%	12↑41.0%	16↑31.0%
Total Liabilities	24	8↓67.2%	10↑29.8%	13↑30.4%	18↑37.3%
Total Equity	69	160↑133.7%	277↑72.8%	255↓7.8%	346↑35.4%
Total Debt	13	0	1	1↓50.0%	1↑123.4%
Net Debt	-62	-48↑23.0%	-142↓197.8%	-79↑44.2%	-160↓101.8%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-30	-42↓40.3%	-49↓17.4%	-67↓37.2%	-70↓3.9%
Capital Expenditure	-1	-0↑41.8%	-0↑19.1%	-0↑81.1%	-0↑19.2%
Free Cash Flow	-30	-42↓38.7%	-49↓17.1%	-67↓36.6%	-70↓3.9%
Stock-Based Comp	2	8↑381.7%	11↑32.2%	26↑137.1%	16↓38.8%
Net Change in Cash	62	-27↓143.5%	96↑451.8%	-63↓166.3%	82↑228.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance